Testing a clinical staging model for bipolar disorder using longitudinal life chart data

Afra van der Markt, Ursula M.H. Klumpers, Stasja Draisma, Annemiek Dols, Willem A. Nolen, Robert M. Post, Lori L. Altshuler, Mark A Frye, Heinz Grunze, Paul E. Keck, Susan L. McElroy, Trisha Suppes, Aartjan T.F. Beekman, Ralph W. Kupka

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: Bipolar disorder has a wide range of clinical manifestations which may progress over time. The aim of this study was to test the applicability of a clinical staging model for bipolar disorder and to gain insight into the nature of the variables influencing progression through consecutive stages. Methods: Using retrospectively reported longitudinal life chart data of 99 subjects from the Stanley Foundation Bipolar Network Naturalistic Follow-up Study, the occurrence, duration and timely sequence of stages 2-4 were determined per month. A multi-state model was used to calculate progression rates and identify determinants of illness progression. Stages 0, 1 and several other variables were added to the multi-state model to determine their influence on the progression rates. Results: Five years after onset of BD (stage 2), 72% reached stage 3 (recurrent episodes) and 21% had reached stage 4 (continuous episodes), of whom 8% recovered back to stage 3. The progression from stage 2 to 3 was increased by a biphasic onset for both the depression-mania and the mania-depression course and by male sex. Conclusions: Staging is a useful model to determine illness progression in longitudinal life chart data. Variables influencing transition rates were successfully identified.

Original languageEnglish (US)
JournalBipolar Disorders
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Bipolar Disorder
Depression

Keywords

  • biphasic onset
  • bipolar disorder
  • male sex
  • mood disorders
  • multi-state model
  • staging
  • staging models

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

van der Markt, A., Klumpers, U. M. H., Draisma, S., Dols, A., Nolen, W. A., Post, R. M., ... Kupka, R. W. (Accepted/In press). Testing a clinical staging model for bipolar disorder using longitudinal life chart data. Bipolar Disorders. https://doi.org/10.1111/bdi.12727

Testing a clinical staging model for bipolar disorder using longitudinal life chart data. / van der Markt, Afra; Klumpers, Ursula M.H.; Draisma, Stasja; Dols, Annemiek; Nolen, Willem A.; Post, Robert M.; Altshuler, Lori L.; Frye, Mark A; Grunze, Heinz; Keck, Paul E.; McElroy, Susan L.; Suppes, Trisha; Beekman, Aartjan T.F.; Kupka, Ralph W.

In: Bipolar Disorders, 01.01.2018.

Research output: Contribution to journalArticle

van der Markt, A, Klumpers, UMH, Draisma, S, Dols, A, Nolen, WA, Post, RM, Altshuler, LL, Frye, MA, Grunze, H, Keck, PE, McElroy, SL, Suppes, T, Beekman, ATF & Kupka, RW 2018, 'Testing a clinical staging model for bipolar disorder using longitudinal life chart data', Bipolar Disorders. https://doi.org/10.1111/bdi.12727
van der Markt, Afra ; Klumpers, Ursula M.H. ; Draisma, Stasja ; Dols, Annemiek ; Nolen, Willem A. ; Post, Robert M. ; Altshuler, Lori L. ; Frye, Mark A ; Grunze, Heinz ; Keck, Paul E. ; McElroy, Susan L. ; Suppes, Trisha ; Beekman, Aartjan T.F. ; Kupka, Ralph W. / Testing a clinical staging model for bipolar disorder using longitudinal life chart data. In: Bipolar Disorders. 2018.
@article{3de35459c30e4d4b9247bb717b3f0c77,
title = "Testing a clinical staging model for bipolar disorder using longitudinal life chart data",
abstract = "Objective: Bipolar disorder has a wide range of clinical manifestations which may progress over time. The aim of this study was to test the applicability of a clinical staging model for bipolar disorder and to gain insight into the nature of the variables influencing progression through consecutive stages. Methods: Using retrospectively reported longitudinal life chart data of 99 subjects from the Stanley Foundation Bipolar Network Naturalistic Follow-up Study, the occurrence, duration and timely sequence of stages 2-4 were determined per month. A multi-state model was used to calculate progression rates and identify determinants of illness progression. Stages 0, 1 and several other variables were added to the multi-state model to determine their influence on the progression rates. Results: Five years after onset of BD (stage 2), 72{\%} reached stage 3 (recurrent episodes) and 21{\%} had reached stage 4 (continuous episodes), of whom 8{\%} recovered back to stage 3. The progression from stage 2 to 3 was increased by a biphasic onset for both the depression-mania and the mania-depression course and by male sex. Conclusions: Staging is a useful model to determine illness progression in longitudinal life chart data. Variables influencing transition rates were successfully identified.",
keywords = "biphasic onset, bipolar disorder, male sex, mood disorders, multi-state model, staging, staging models",
author = "{van der Markt}, Afra and Klumpers, {Ursula M.H.} and Stasja Draisma and Annemiek Dols and Nolen, {Willem A.} and Post, {Robert M.} and Altshuler, {Lori L.} and Frye, {Mark A} and Heinz Grunze and Keck, {Paul E.} and McElroy, {Susan L.} and Trisha Suppes and Beekman, {Aartjan T.F.} and Kupka, {Ralph W.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bdi.12727",
language = "English (US)",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",

}

TY - JOUR

T1 - Testing a clinical staging model for bipolar disorder using longitudinal life chart data

AU - van der Markt, Afra

AU - Klumpers, Ursula M.H.

AU - Draisma, Stasja

AU - Dols, Annemiek

AU - Nolen, Willem A.

AU - Post, Robert M.

AU - Altshuler, Lori L.

AU - Frye, Mark A

AU - Grunze, Heinz

AU - Keck, Paul E.

AU - McElroy, Susan L.

AU - Suppes, Trisha

AU - Beekman, Aartjan T.F.

AU - Kupka, Ralph W.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Bipolar disorder has a wide range of clinical manifestations which may progress over time. The aim of this study was to test the applicability of a clinical staging model for bipolar disorder and to gain insight into the nature of the variables influencing progression through consecutive stages. Methods: Using retrospectively reported longitudinal life chart data of 99 subjects from the Stanley Foundation Bipolar Network Naturalistic Follow-up Study, the occurrence, duration and timely sequence of stages 2-4 were determined per month. A multi-state model was used to calculate progression rates and identify determinants of illness progression. Stages 0, 1 and several other variables were added to the multi-state model to determine their influence on the progression rates. Results: Five years after onset of BD (stage 2), 72% reached stage 3 (recurrent episodes) and 21% had reached stage 4 (continuous episodes), of whom 8% recovered back to stage 3. The progression from stage 2 to 3 was increased by a biphasic onset for both the depression-mania and the mania-depression course and by male sex. Conclusions: Staging is a useful model to determine illness progression in longitudinal life chart data. Variables influencing transition rates were successfully identified.

AB - Objective: Bipolar disorder has a wide range of clinical manifestations which may progress over time. The aim of this study was to test the applicability of a clinical staging model for bipolar disorder and to gain insight into the nature of the variables influencing progression through consecutive stages. Methods: Using retrospectively reported longitudinal life chart data of 99 subjects from the Stanley Foundation Bipolar Network Naturalistic Follow-up Study, the occurrence, duration and timely sequence of stages 2-4 were determined per month. A multi-state model was used to calculate progression rates and identify determinants of illness progression. Stages 0, 1 and several other variables were added to the multi-state model to determine their influence on the progression rates. Results: Five years after onset of BD (stage 2), 72% reached stage 3 (recurrent episodes) and 21% had reached stage 4 (continuous episodes), of whom 8% recovered back to stage 3. The progression from stage 2 to 3 was increased by a biphasic onset for both the depression-mania and the mania-depression course and by male sex. Conclusions: Staging is a useful model to determine illness progression in longitudinal life chart data. Variables influencing transition rates were successfully identified.

KW - biphasic onset

KW - bipolar disorder

KW - male sex

KW - mood disorders

KW - multi-state model

KW - staging

KW - staging models

UR - http://www.scopus.com/inward/record.url?scp=85058366005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058366005&partnerID=8YFLogxK

U2 - 10.1111/bdi.12727

DO - 10.1111/bdi.12727

M3 - Article

C2 - 30447123

AN - SCOPUS:85058366005

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

ER -